Recurrent Deep Vein Thrombosis

Labropoulos, Nicos; Jen, James; Jen, Henry; Gasparis, Antonios P.; Tassiopoulos, Apostolos K.

doi:10.1097/sla.0b013e3181d568db

Cited by 54 publications

(18 citation statements)

References 34 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Some authors have reported a slightly increased risk (hazard ratio 1.36 per increase in each decade of age) (28,29), and others found no relationship (4,6,30), or even a decreased risk with ageing (31). In routine clinical practice, age at first venous thrombosis is usually taken into consideration when a patient is counseled regarding duration of anticoagulant treatment.…”

Section: Potential New Risk Factors For Venous Recurrencementioning

confidence: 99%

Epidemiology of recurrent venous thrombosis

Ribeiro

Lijfering

Barreto

et al. 2012

Braz J Med Biol Res

View full text Add to dashboard Cite

Venous thrombosis, including deep vein thrombosis and pulmonary embolism, is a common disease that frequently recurs. Recurrence can be prevented by anticoagulants, but this comes at the risk of bleeding. Therefore, assessment of the risk of recurrence is important to balance the risks and benefits of anticoagulant treatment. This review briefly outlines what is currently known about the epidemiology of recurrent venous thrombosis, and focuses in more detail on potential new risk factors for venous recurrence. The general implications of these findings in patient management are discussed.

show abstract

Section: Potential New Risk Factors For Venous Recurrencementioning

confidence: 99%

Epidemiology of recurrent venous thrombosis

Ribeiro

Lijfering

Barreto

et al. 2012

Braz J Med Biol Res

View full text Add to dashboard Cite

show abstract

“…The cumulative incidence of recurrence was ≈ 16% after a mean followup of 1216 days from the initial VTE event in the patients included in the Worcester VTE study [19]. An incidence of recurrence of 26.1% at 5 years was recorded in a small series of patients with DVT by Labropoulos et al [20]. Poli et al [21] have prospectively followed a series of 206 patients with acute PE.…”

Section: Incidence Of Vte Recurrencementioning

confidence: 99%

Recurrent Venous Thromboembolism: What Is the Risk and How to Prevent It

Palareti¹

2012

Scientifica

View full text Add to dashboard Cite

Venous thromboembolism (VTE) that includes deep vein thrombosis and/or pulmonary embolism is a frequent, severe, and potentially lethal disease. After a first episode, VTE has a strong tendency to recur. While VTE is an acute disease, it may have variable outcomes in early and late phases after initial presentation. Furthermore, the incidence of late, clinically important consequences (postthrombotic syndrome and/or chronic thromboembolic pulmonary hypertension) increases in case of recurrent events. The aims of the present review are (i) to analyze the incidence and risk factors for recurrence of VTE (either those related to the type of first thrombotic event or to the patients), the risks associated with occurrence of recurrent events, and the problems linked to the diagnosis, not always easy, of recurrent events; (ii) to discuss whether or not it is possible to predict the individual risk of recurrence after a first event, by stratifying patients at high or low risk of recurrence, and how this can influence their treatment; (iii) to comment what the current guidelines and guidance suggest/recommend about anticoagulant treatment after a first VTE event and, finally, to propose practical indications on how to manage individual patients affected by VTE.

show abstract

“…Obrzęk i ból go le ni są naj bar dziej ty po wy mi, wcze sny mi ob ja wami roz wi ja ją cej się za krze pi cy żyl nej. Niele czo na ostra za krze pi ca żył głę bo kich pro wa dzi w 33-50% do zato ro wo ści płuc nej [2,[3][4][5][6].…”

Section: Wstępunclassified

“…The most typical early manife stations of a developing venous thrombosis include oedema and tibial pain. Uncontrolled acute deep vein thrombosis leads to pulmonary embolism in 33-50% of patients [2,[3][4][5][6].…”

Section: Wy Tycz Ne Mię Dzy Na Ro Do We I Pol Skie Pro Fi Lak Ty Ki Vtementioning

confidence: 99%

“…The study group included 81 patients who had undergone hip arthroscopy between October 2004 and July 2008 [36]. Preliminary preopera tive diagnoses in the study group were: injury to glenoid lip (71 cases), snapping hip (3), loose bodies (6), biopsy of the head of the femur (1), synovectomy (1) and posttraumatic debridement (1). All patients 1, po ura zo wy de bri de ment 1.…”

Section: Hip Arthroscopymentioning

confidence: 99%

See 1 more Smart Citation

Venous Thromboembolism Prophylaxis in Arthroscopic Surgery

Bryll

Płomiński

2013

Ortop Traumatol Rehabil

View full text Add to dashboard Cite

The prophylaxis and epidemiology of venous thromboembolism (VTE) following major orthopaedic procedures has been widely discussed in the world literature. Significantly less attention in the recent years has been paid to antithrombotic prophylaxis following arthroscopic procedures. In the past few years numerous controversies have developed as a result of contradictory guidelines advocated by various centres. Clinical studies involving prospective patient groups result in guidelines being published by orthopaedic associations. The guidelines issued by the Ame-rican College of Chest Physicians (ACCP) are the most influential. The latest edition of the guidelines was published in 2012. The National Institute for Health and Clinical Excellence (NICE) is a British centre which issues guidelines for antithrombotic prophylaxis. The latest version of the guidelines is the Clinical Guidelines (CG) 92, dated 2010. Polish guidelines were developed by a working group headed by Prof. Krystyna Zawilska. The Polish Society of Orthopaedics and Traumatology (PSOT) has not endorsed or recommended the guidelines put forward by the Working Group in 2012, so the PSOT guidelines are valid regarding orthopaedics and arthroscopic procedures. The comparison of international and Polish guidelines indicates a considerable discrepancy between the approaches to antithrombotic prophylaxis in arthroscopic procedures. From the viewpoint of an orthopaedist it is most important to select a prophylactic procedure appropriate for a specific patient. It is necessary to explain the need of prophylaxis to the patient, assess the risk factors of thrombosis and employ reliable tools, such as Wells' score. Pharmacological prophylaxis is well-known and widely used in arthroscopic procedures in Polish centres. However, it is also important to implement mechanical prophylactic measures, which are neglected or used to a limited extent in numerous centres. In recent years, American researchers conducted studies of large groups of patients with regard to the prophylaxis and incidence of VTE following arthroscopic procedures of the knee, hip and shoulder. The incidence of VTE following knee, hip and shoulder arthroscopy was 0.42%, 3.7% and 0.31%, respectively. The findings of the study support the validity of the guidelines issued by the American College of Chest Physicians in 2012.

show abstract

Recurrent Deep Vein Thrombosis

Cited by 54 publications

References 34 publications

Epidemiology of recurrent venous thrombosis

Epidemiology of recurrent venous thrombosis

Recurrent Venous Thromboembolism: What Is the Risk and How to Prevent It

Venous Thromboembolism Prophylaxis in Arthroscopic Surgery

Contact Info

Product

Resources

About